SENNA WITH DOCUSATE SODIUM

Manufacturer: HHH Pharmaceuticals | Elysium Pharmaceuticals Ltd
Effective date: 2025-10-08
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 01:38:28

Label at a glance#

ProductSENNA WITH DOCUSATE SODIUM

Active ingredientSENNOSIDES, DOCUSATE SODIUM

Label structure9 sections

Indications and uses

relieves occasional constipation (irregularity) generally causes bowel movement in 6-12 hours

Dosage and administration

take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage adults and children 12 years of age and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years ½ tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor

Storage and handling

each tablet contains: calcium 21 mg, sodium 3 mg. VERY LOW SODIUM store at 25ºC (77ºF); excursions permitted between 15°-30°C (59°-86°F) DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Contacts and useful links#

PhoneLabel contact1-302-380-3408

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredients (in each tablet) Purpose

Docusate sodium 50 mg.......................................Stool softner

Sennosides 8.6 mg................................................Laxative

Uses

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)
generally causes bowel movement in 6-12 hours

Warnings

WARNINGS SECTION

Do not use

SPL UNCLASSIFIED SECTION

if you are now taking mineral oil, unless directed by a doctor
laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

stomach pain
nausea
vomiting
noticed a sudden change in bowel habits that continues over a period of 2 weeks.

Stop use and ask a doctor if

OTC - STOP USE SECTION

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
adults and children 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	½ tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

Other information

STORAGE AND HANDLING SECTION

each tablet contains: calcium 21 mg, sodium 3 mg. VERY LOW SODIUM
store at 25ºC (77ºF); excursions permitted between 15°-30°C (59°-86°F)
DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Inactive ingredients

INACTIVE INGREDIENT SECTION

croscarmellose sodium, colloidal silicon dioxide, dicalcium phosphate, polyethylene glycol, FD&C red 40 lake, hypromellose, magnesium stearate, microcrystalline cellulose, stearic acid powder, titanium dioxide.

Questions or comments?

OTC - QUESTIONS SECTION

call toll-free 1-302-380-3408

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	1
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	1
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
83586-001-00	SENNA WITH DOCUSATE SODIUM	50000 in 1 DRUM	TABLET	50000		1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

SENNA WITH DOCUSATE SODIUM
Docusate Sodium and Sennosides
CROSCARMELLOSE SODIUM
SILICON DIOXIDE
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
POLYETHYLENE GLYCOL, UNSPECIFIED
FD&C RED NO. 40 ALUMINUM LAKE
HYPROMELLOSES
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
STEARIC ACID
TITANIUM DIOXIDE
SENNOSIDES
DOCUSATE SODIUM
DOCUSATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
83586-001	83586-001-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	L11K75P92J	IACT
POLYETHYLENE GLYCOL, UNSPECIFIED	3WJQ0SDW1A	IACT
FD&C RED NO. 40 ALUMINUM LAKE	6T47AS764T	IACT
HYPROMELLOSES	3NXW29V3WO	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
STEARIC ACID	4ELV7Z65AP	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
SENNOSIDES	3FYP5M0IJX	ACTIB
DOCUSATE SODIUM	F05Q2T2JA0	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SENNA WITH DOCUSATE SODIUM	DOCUSATE SODIUM AND SENNOSIDES	HHH Pharmaceuticals	2bbb1b99-d43c-40a3-bc53-e18e8394c318	2025-10-08	Warnings	Exact identifier ndc (package): 83586-001-00 ndc (product): 83586-001 ndc11 (package): 83586000100 spl id: 40a17a93-869f-c593-e063-6394a90ad242 spl set id: 2bbb1b99-d43c-40a3-bc53-e18e8394c318

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.